Largest Biopharmaceuticals Public Companies in Italy

Company	HQ	Description	Sectors	Stock Price	1Y Perf.	Market Cap	EV	EV/Revenue	EV/EBITDA
Recordati		Recordati SpA is a drug manufacturing company that focuses on specialt…Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.	Biopharmaceuticals	$60	-2%	$12B	$14B	4.7x	12.3x
Philogen		Philogen SpA is a biotechnology company. The company develops biotech…Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.	Biopharmaceuticals	$26	+2%	$1B	$635M	1.7x	2.1x
Newron Pharmaceuticals		Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmace…Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson’s disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Geographically the research and development activities are performed in Italy and the United States.	Biopharmaceuticals	$18	+92%	$373M	$384M	17.3x	(75.3x)
Arterra Bioscience		Arterra Bioscience SpA is a biotechnology company focused on the resea…Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.	Biopharmaceuticals	$3	+27%	$22M	$21M	3.7x	7.7x
Genenta Science		Genenta Science SPA is a clinical-stage biotechnology company engaged…Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.	Biopharmaceuticals	$1	-87%	$14M	($10M)	-	1.3x
Median				$18	+2%	$373M	$384M	4.2x	2.1x

Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.